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Hepatocarcinogenesis-resistant DRH rats exhibit few and small preneoplastic hepatocytic lesions during hepatocarcinogenesis, of
which traits have been assigned to two major chromosomal regions, Drh1 and Drh2. In this study, hepatocytes from DRH.F344-
Drh1, a congenic strain in which the Drh1 chromosomal region was replaced with that of F344 rats, were compared to
hepatocytes from Donryu (original strain), DRH, and F344 rats. Although DRH hepatocytes exhibited low proliferation and p38
dephosphorylation after lead nitrate (LN) treatment despite cytokine and Cox2 activation, DRH.F344-Drh1 hepatocytes exhibited
high responses, as did Donryu and F344 hepatocytes. Moreover, although DRH hepatocytes were resistant to hepatotoxins,
DRH.F344-Drh1 hepatocytes were as sensitive to hepatotoxins as Donryu and F344 hepatocytes. However, DRH.F344-Drh1
hepatocytes like DRH hepatocytes proliferated at lower rates in vitro and contained smaller nuclei than Donryu and F344
hepatocytes. Thus, low responses to LN and resistance to hepatotoxins in DRH hepatocytes were linked to the Drh1 locus, while
low proliferation in vitro and small nuclear size were not linked to the Drh1 locus.
1.Introduction
DRH rats were established by the selective mating of
Donryu rat progeny that exhibited resistance to hepatocar-
cinogenesis induced by the feeding of a 3 -methyl-4-dime-
thylaminoazobenzene (3 -Me-DAB) diet [1, 2]. DRH rats
exhibit hepatocarcinogenesis resistance to 3 -Me-DAB as
well as other hepatocarcinogens [3]. In DRH rats, preneo-
plastic hepatocytic lesions are smaller in size and fewer in
number than those of ordinary rats [4, 5]. Genetic analysis
hasdemonstratedthatresistanceisadominanttraitinacross
of DRH and Donryu rats [4] and that the number and size
of preneoplastic hepatocytic lesions and the expression levels
of glutathione-S-transferase-placental form (GST-P) mRNA
and protein, a marker for preneoplastic hepatocytes, are
strongly aﬀected by highly signiﬁcant quantitative trait loci
(QTL) on rat chromosomes 1q (Drh1)a n d4 q( Drh2)[ 5, 6].
It has also been shown that the small size of preneoplastic
hepatocytic lesions might be dependent mainly on the
tissue environment; that is, transplanted DRH preneoplastic
hepatocyteswereobserved to formlargecolonies in thelivers
of Donryu rats treated with dietary 2-acetylaminoﬂuorene
(2-AAF) plus partial hepatectomy (PH), which enables the
selective growth of preneoplastic hepatocytes [7], and trans-
planted Donryu preneoplastic hepatocytes formed small
colonies within the livers of DRH rats treated with the same
protocol [8].
DRH hepatocytes have a number of unique properties
compared to hepatocytes of ordinary rats. First, DRH hep-
atocytes exhibit less proliferation after treatment with lead
nitrate (LN) [4, 9], a nonnecrogenic hepatocyte proliferating
agent [10], which is thought to be mediated, at least in part,
by the cytokines generated by activated Kupﬀer cells [11, 12].
Second, DRH hepatocytes are resistant to various hepa-
totoxic chemicals, including carbon tetrachloride (CCl4),2 International Journal of Hepatology
diethylnitrosamine (DEN), thioacetamide, 2-AAF, and 3 -
Me-DAB [8]. Third, in primary culture, DRH hepatocytes
exhibited less apoptosis and lower activation of p38 and Jun
terminal kinase (JNK) than Donryu hepatocytes, although
the expression levels of 8-hydroxyguanine and p53/p21 pro-
teins that reﬂect DNA damage [13, 14]w e r ec o m p a r a b l et o
those of Donryu hepatocytes [15]. Fourth, DRH hepatocytes
are smaller in size than Donryu hepatocytes [15]. If some
of these properties of DRH hepatocytes are linked to the
Drh1or Drh2locus, then the properties might also be related
to the mechanism(s) of hepatocarcinogenesis resistance in
DRH rats.
DRH.F344-Drh1 rats represent the congenic DRH strain
in which the chromosome 1 segment that includes the
Drh1 locus is substituted with that of F344 rats [9].
These rats exhibit a high incidence of GST-P(+) foci in
response to treatment with 3 -Me-DAB/PH and high liver
cell proliferation after LN treatment, comparable to that
in F344 rats, but formed intermediate-sized GST-P(+) foci
and exhibited intermediate GST-P mRNA expression levels
between the levels of F344 and those of DRH rats after
treatmentwithDENfollowedbydietary3 -Me-DAB/PH[9].
This ﬁnding indicates that the Drh1 locus contributes to the
low incidence of GST-P(+) focus formation and the low level
of liver cell proliferation in response to LN treatment, but
it does not fully explain the smaller size of the GST-P(+)
foci. In the present study, we investigated which properties of
DRH hepatocytes are linked to the Drh1 locus by comparing
the hepatocytes of DRH.F344-Drh1 rats with those of DRH,
Donryu and F344 rats in vivo and in vitro.
2.MaterialsandMethods
2.1. Animals and Treatments. Male 8- to 10-week-old
DRH.F344-Drh1 (kindly provided by Dr. Hiai, Medical Cen-
ter of the Shiga Prefecture, Japan), DRH (Seak Yoshitomi,
Fukuoka, Japan), Donryu (Charles River, Tokyo, Japan),
and F344 rats (Charles River) were used. The Drh1 locus
on chromosome 1 of these rats is illustrated in Figure 1.
The animals were maintained in 12h light/dark cycles and
given laboratory rodent pellet chow (Oriental, Tokyo, Japan)
and water ad libitum. One group of rats was intravenously
administered LN at a dose of 100mmole/kg body weight,
given bromodeoxyuridine (BrdU) on day 1, 2, or 3 after
LN treatment, and sacriﬁced 1h after BrdU treatment. The
liver tissues were perfusion-ﬁxed with a 10% buﬀered-
formalinsolution,immersedinﬁxativesolutionfor24h,and
then processed for paraﬃn embedding. The tissue sections
were immunostained using an anti-BrdU antibody (Becton
Dickinson, San Jose, Calif, USA), and the BrdU labeling
index (LI) of hepatocytes was determined microscopically.
Other groups of rats were administered DEN dissolved in
physiological saline at a dose of 200mg/kg body weight by
intraperitoneal injection or CCl4 dissolved in olive oil at a
dose of 5mL/kg body weight by gastric tube and sacriﬁced
24h later. Blood samples were taken from each rat, and
serum was isolated to measure alanine aminotransferase
(ALT) and aspartate aminotransferase (AST) levels. All
animal procedures were approved by the Asahikawa Medical
Donryu DRH F344
Chromosome 1
Drh1 Drh1 Drh1 Drh1
DRH.F344-Drh1
Figure 1: Schematic representation of the Drh1 locus on chro-
mosome 1 in Donryu, DRH, DRH.F344-Drh1, and F344 rats.
In DRH.F344-Drh1 rats, the region including the Drh1 locus is
substituted with that of F344 rats.
College committee according to the guidelines for humane
care of laboratory animals and conducted according to the
Asahikawa Medical College committee of animal care and
use.
2.2. Primary Hepatocyte Culture and Cell Proliferation Assay.
Hepatocytes were isolated using a collagenase perfusion
method [16] and plated on 12-well plates. They were ﬁrst
cultured in Williams’ E medium with 10% fetal bovine
serum(FBS)for24handthenculturedinhepatocytegrowth
medium (HGM) [17] supplemented with 5U/mL penicillin,
100μg/mL streptomycin, and various concentrations of EGF
(0, 1, 10, or 50ng/mL) or HGF (0, 5, 20, or 100ng/mL) for
3 days. The cultured hepatocytes were treated with [3H]-
thymidine for 3 days after beginning culture with HGM, and
[3H]-thymidine incorporation into DNA was determined
using a liquid scintillation counter (Beckmann-Coulter,P a l o
Alto, Calif, USA).
2.3. Nuclear Size Analysis. Freshly isolated hepatocytes were
plated on a 15mm diameter cover glass coated with Cellma-
trix Type 1-A (Nitta Gelatin, Tokyo, Japan) in Williams’ E
medium supplemented with 10% FBS, cultured for 2h to
allow attachment to the cover glass, ﬁxed in 1% buﬀered-
formalin solution and stained by DAPI. The cells were
observed under a ﬂuorescence microscope (Nikon, Tokyo,
Japan)equippedwithacool-scanningdigitalcamera(Hama-
matsu Photonics, Hamamatsu, Japan). Nonﬂuorescent and
DAPI-stained nuclear images of hepatocytes were saved as
Photoshop ﬁles, and each cell was divided into small single-
or double-, medium single- or double- or large single-
or double-nuclear cells using ImageJ software (National
Institute of Health, Bethesda, Md, USA). At least 500
hepatocytesweremeasuredforeachrat,usingthreeratsfrom
each strain.
2.4. Western Blot Analysis. Protein lysates were prepared
from liver tissue samples, run on 8–13% polyacrylamide
gels containing 0.1% sodium dodecyl sulfate and transferred
to PVDF membranes (Amersham, Uppsala, Sweden). The
membranes were probed with primary antibodies and then
hybridized with horseradish peroxidase- (HRP-) conjugated
anti-rabbit immunoglobulin (Amersham). The bound anti-
bodies were detected using an ECL-plus kit (Amersham).International Journal of Hepatology 3
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Figure 2: Proliferation of hepatocytes in Donryu, DRH, DRH.F344-Drh1, and F344 rats after LN treatment. (a) Day 2 after LN treatment.
BrdU(+) hepatocyte nuclei occurred frequently in Donryu, DRH.F344-Drh1, and F344 livers but occurred much less frequently in DRH
livers. (b) The BrdU LI in hepatocytes was most strongly increased on day 2 after LN treatment in Donryu, DRH.F344-Drh1, and F344 livers
but was much lower in DRH livers. ∗P<0.05 in comparison with DRH (n = 5) against Donryu (n = 5), DRH.F344-Drh1 (n = 4), or F344
(n = 8).
2.5. Electromobility Shift Assay (EMSA). EMSA was per-
formed for nuclear extracts of LN-treated liver tissues, and
theDNA-proteincomplexeswereresolvedona6%polyacry-
lamide gel. A biotin-labeled oligonucleotide representing an
NFκB consensus site (5 -AGTTGAGGGGACTTTCCCAGG-
C-3 ) and a Stat3 consensus site (5 -TTCTGGGAATT-3 )
was used as a probe.
2.6. Real-Time RT-PCR. Fresh liver samples were isolated at
0,3,6,12,and24hafterLNtreatment,frozeninliquidnitro-
g e n ,a n ds t o r e da t−80◦C until further use. RNA was isolated
with Sepazol and reverse-transcribed using the generic oligo
dT primer and reverse transcriptase (Invitrogen, Carlsbad,
Calif, USA). The following PCR primers were used: for TNF-
α,5  -CCCATTTGGGAACTTCTCCT-3  (forward) and 5 -
AGATGTGGAACTGGCAGAGG-3  (reverse); for IL-6, 5 -
GCCCTTCAGGAACAGCTATG-3  (forward) and 5 -TCA-
GTCCCAAGAAGGCAACT-3  (reverse); for Cox2, 5 -GAG-
ATACGTGTTGACGTCC-3  (forward) and 5 -ACTGAT-
GAGTGAAGTGCTGG-3  (reverse). Real-time RT-PCR was
performed using a LightCycler (Roche Molecular Biochem-
icals, Basel, Switzerland) with LightCycler3 Run software
(version 5.32). Fluorescence was generated by a Platinum
SYBR Green qPCR SuperMix UDG, and data were collected
with LightCycler3 Data Analysis software (version 3.5.28).
2.7. Statistical Analysis. Each experiment was performed at
least three times, and representative data are shown. Data
in bar graphs are given as the mean ± SD. The means were
analyzed using Student’s t-test or ANOVA, and P values less
than 0.05 were considered statistically signiﬁcant.
3. Results
3.1. Hepatocyte Proliferation, Cytokine Activation, and p38
MAPK Hypophosphorylation after LN Treatment. When
Donryu, DRH, DRH.F344-Drh1, and F344 rats were treated
withLN,theBrdULImarkedlyincreasedinDRH.F344-Drh1
h e p a t o c yt e so nd a y2a sr e p o rt e db yL i ue ta l .[ 9], similarly to
the increases observed in Donryu and F344 hepatocytes, but
the BrdU LI did not increase in DRH hepatocytes (Figures
2(a) and 2(b)), indicating that the Drh1 l o c u si sl i n k e dt o
the low response of DRH hepatocytes to LN. It has been
suggested that hepatocyte proliferation induced by LN is
mediated at least partly by cytokines such as TNF-α and IL-
6, which are generated by activated Kupﬀer cells [11, 12].
In addition, Cox2 protein expression in activated Kupﬀer
cells, which leads to the overproduction of prostaglandins,
has been shown to play an important role in hepatocyte
proliferation [18]. Furthermore, when Donryu rats were
treated with indomethacin, a Cox1/2 inhibitor, prior to and
after LN treatment, the BrdU LI of hepatocytes decreased to
approximately50%ofthevaluesafterLNtreatmentaloneon
day 2, indicating that prostaglandins at least partly mediate
hepatocyte proliferation after LN treatment (unpublished
data by M. Yamamoto). We therefore investigated whether4 International Journal of Hepatology
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Figure 3: TNF-α, IL-6, and Cox2 mRNA expression levels and NFκB/Stat3 activation after LN treatment. (a) Quantitative RT-PCR revealed
that TNF-α, IL-6, and Cox2 mRNA expression levels peaked at 6h after LN treatment in Donryu, DRH, and DRH.F344-Drh1 livers. (b)
EMSA for NFκB (upper panel) and Stat3 (lower panel). Both NFκB and Stat3 were most strongly activated at 6h after LN treatment in
Donryu, DRH, and DRH.F344-Drh1 livers. NS: nonspeciﬁc bands.
the Drh1 locus plays a role in cytokine and Cox2 activation
after LN treatment. As shown in Figure 3(a),T N F - α,I L -
6, and Cox2 mRNA expression levels were increased to the
same extent from 3 to 12h after LN treatment, peaking at
6h in DRH.F344-Drh1, Donryu, and DRH livers, suggesting
that the Drh1 locus is not related to cytokine and Cox2
activation after LN treatment. Because TNF-α and IL-6
can activate NFκB and Stat3, respectively, which are tran-
scription factors that play an important role in hepatocyte
proliferation [19], we investigated NFκB/Stat3 activation by
EMSA using nuclear lysates prepared from LN-treated livers
and NFκB/Stat3-speciﬁc oligonucleotide probes. Figure 3(b)
illustrates that NFκB/Stat3 activation occurred 6–16h after
LN treatment, with a peak at 6h, in Donryu, DRH, and
DRH.F344-Drh1 livers.
It has been reported that when the liver is exposed to
toxic chemicals, the phosphorylation status of MAPK path-
way proteins, including ERK1/2, JNK, and p38, ﬂuctuates
shortly after exposure [20–22]. We therefore investigated
whether there was any diﬀerence in the phosphorylation
status of MAPKs after LN treatment in the livers of
Donryu, DRH, DRH.F344-Drh1, and F344 rats. ERK1/2,
which was hypophosphorylated in normal livers, became
hyperphosphorylated 3–12h after LN treatment, whereasInternational Journal of Hepatology 5
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Figure 4: The phosphorylation status of p38 after LN treat-
ment. Although p38 was hyperphosphorylated in normal livers of
Donryu, DRH, DRH.F344-Drh1, and F344 rats, it was markedly
hypophosphorylated in Donryu, DRH.F344-Drh1, and F344 livers
at 12h after LN treatment, but p38 hypophosphorylation occurred
at much lower degrees in DRH livers.
JNK, which was also hypophosphorylated in normal livers,
showed no remarkable change in phosphorylation status
after LN treatment in all rats (data not shown). However,
although p38 was hyperphosphorylated in the normal livers
of all Donryu, DRH, DRH.F344-Drh1, and F344 rats, as
reported previously [20–22], it became hypophosphorylated
after LN treatment in Donryu, DRH.F344-Drh1, and F344
livers, peaking at 12h, but such hypophosphorylation was at
much less degree in DRH livers (Figure 4).
3.2. Susceptibility of Hepatocytes to Hepatotoxic Chemicals.
DRH hepatocytes have been demonstrated to be resistant
to various hepatotoxic chemicals, including CCl4, thioac-
etamide, DEN, 2-AAF, and 3 -Me-DAB [8]. To test the role
of the Drh1 locus in hepatotoxin susceptibility, Donryu,
DRH, DRH.F344-Drh1, and F344 rats were administered
200mg/kg DEN or 5mL/kg CCl4 to compare liver injury
24h after treatment. After DEN treatment, serum ALT and
AST levels in DRH.F344-Drh1 rats were as high as those in
Donryu and F344 rats, while these levels were signiﬁcantly
lower in DRH rats (Figure 5(a)). After CCl4 treatment, DRH
rats exhibited a lower degree of hepatic injury than Donryu
rats as previously reported [8], while F344 rats also showed
the lower degree of injury than Donryu rats (Figure 5(b)),
presumably because the factor(s) other than the Drh1 locus
thatwasinvolvedtotheCCl4 susceptibilitymightbediﬀerent
between Donryu and F344 rats. However, DRH.F344-Drh1
rats exhibited a higher degree of hepatic injury than DRH
and F344 rats (Figure 5(b)).
3.3. Hepatocyte Proliferation In Vitro. We next addressed
whether the Drh1 locus plays a role in the proliferative
capacity of hepatocytes. For this purpose, hepatocytes were
isolatedfromDonryu,DRH,DRH.F344-Drh1,andF344rats
and cultured in the presence of various concentrations of
EGF (0, 1, 10, or 50ng/mL) or HGF (0, 5, 20, or 100ng/mL).
Because [3H]-thymidine uptake increased beginning on day
1 after growth factor treatment and peaked on day 3 in
the hepatocytes of all rats (data not shown), the cells were
then incubated with [3H]-thymidine between days 1 and 3.
Uptake of [3H]-thymidine into hepatocyte DNA increased
after EGF or HGF treatment in all rats, but DRH.F344-
Drh1 and DRH hepatocytes exhibited approximately 50–
70% of the uptake observed in Donryu and F344 hepatocytes
(Figures 6(a) and 6(b)).
3.4. Nuclear Size. The DRH hepatocytes are smaller in size
than Donryu hepatocytes [15]. We therefore compared the
nuclear sizes of Donryu, DRH, DRH.F344-Drh1, and F344
hepatocytes collected from 8-week-old rats. When the DAPI-
stained nuclear images of hepatocytes cultured for 2h on
coverglasswereanalyzedbyImageJsoftware,thenuclearsize
could be categorized into small, medium, and large classes
(data not shown). Approximately 60% of DRH.F344-Drh1
and DRH hepatocytes had single- or double-small-sized
nuclei, while the remainder had single-medium-sized nuclei
(Figures 7(a) and 7(b)). By contrast, 10–15% of Donryu
and F344 hepatocytes had double-small-sized nuclei, while
the remaining 85–90% had single- or double-medium-sized
nuclei (Figures 7(a) and 7(b)).
4. Discussion
In DRH rats, two major genetic loci, Drh1 on chromosome
1a n dDrh2 on chromosome 4, have been demonstrated to
have strong eﬀects on the number and size of preneoplastic
hepatocytic lesions during hepatocarcinogenesis [5, 6]. DRH
hepatocytes, on the other hand, have unique properties,
includinglowlevelsofproliferationafterLNtreatment[4,9],
resistance to hepatotoxic chemicals [8], small cell size [15]
and low levels of p38 and JNK activation in vitro [15].
If some of these properties are linked to the genetic loci,
then the properties might be related to the mechanism(s) of
hepatocarcinogenesis resistance in DRH rats. By comparing
DRH.F344-Drh1 hepatocytes with Donryu, DRH, and F344
hepatocytes, we demonstrated that low levels of proliferation
and low levels of p38 dephosphorylation after LN treatment
and resistance to hepatotoxic chemicals in DRH hepatocytes6 International Journal of Hepatology
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Figure 5: Liver injury after DEN and CCl4 treatment. (a) After DEN treatment, DRH.F344-Drh1 rats (n = 6) exhibited high AST/ALT
values, similar to those of Donryu (n = 6) and F344 rats (n = 5); these levels were much higher than those of DRH rats (n = 6). ∗P< 0.05.
(b) After CCl4 treatment, DRH.F344-Drh1 rats (n = 10) also exhibited high AST/ALT values, similar to those of Donryu rats (n = 9); these
levels were higher than those of DRH (n = 12) and F344 rats (n = 11). ∗P< 0.05.
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Figure 6: Uptake of [3H]-thymidine into hepatocyte DNA after EGF or HGF treatment. Although [3H]-thymidine uptake was increased
after either EGF (a) or HGF (b) treatment, it was signiﬁcantly lower in DRH and DRH.F344-Drh1 hepatocytes than in Donryu and F344
hepatocytes (∗P<0.05).International Journal of Hepatology 7
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Figure 7: Nuclear size of hepatocytes. (a) DRH.F344-Drh1 and
DRH hepatocytes exhibited mainly single- (S) or double-small-
sized nuclei (2S), while Donryu and F344 hepatocytes exhibited
mainly single- (M) or double-medium-sized nuclei (2M). (b)
Size distribution of hepatocyte nuclei. In DRH.F344-Drh1 and
DRH rats, about 60% hepatocytes contain single- or double-small-
sized nuclei, while other hepatocytes contain single-medium-sized
nuclei. On the other hand, in Donryu and F344 rats, the majority of
hepatocytes contain single- or double-medium-sized nuclei.
Table 1: Comparison of hepatocytes from Donryu, DRH, DRH.
F344-Drh1, and F344 rats.
Donryu DRH DRH.F344-Drh1 F344
Proliferation by LN High Low∗ High∗ High
P38 dephosphorylation High Low∗ High∗ High
Susceptibility to DEN
and CCl4
High Low∗ High∗ High†
Proliferation by GF High Low∗∗ Low∗∗ High
Nuclear size Large Small∗∗ Small∗∗ Large
∗Phenotype diﬀerent between DRH and DRH.F344-Drh1. ∗∗Phenotype
similar between DRH and DRH.F344-Drh1. †High to DEN as Donryu, but
lower to CCl4 than Donryu.
are linked to the Drh1 locus, while low levels of proliferation
in vitro and small nuclear size are not linked to this locus
(Table 1).
It has been suggested that the hepatocyte proliferation
induced by LN is at least partly due to the soluble factors
generated by activated Kupﬀer cells [11, 12]. After LN
treatment, the mRNA levels of TNF-α, IL-6, and Cox2,
which are expressed in activated Kupﬀer cells [23, 24], were
increased, and NFκB and Stat3, which are transcription
factors that can be activated, respectively, by TNF-α and
IL-6 to play important roles in hepatocyte proliferation
[19], were activated. However, there was no remarkable
diﬀerence between DRH, Donryu, and DRH.F344-Drh1
livers regarding cytokine and Cox2 mRNA expression and
NFκB or Stat3 activation after LN treatment, suggesting that
the low level of proliferation of DRH hepatocytes induced
by LN might not be due to the lack of factors that mediate
hepatocyte proliferation; instead, they might be dependent
on the inherent properties of DRH hepatocytes.
It has been reported that, although p38 is hyperphos-
phorylated in normal livers, it becomes hypophosphory-
lated after treatment with chemicals such as CCl4, d-
galactosamine, and thioacetamide [20–22] and that p38
hypophosphorylation is mediated by activation of the phos-
phatase MKP-1 [20]. In the present study, we demonstrated
that p38 dephosphorylation also occurred after LN treat-
ment, an eﬀect that was dependent on the Drh1 locus.
Although the mechanism of p38 dephosphorylation induced
by LN is unknown, this phenomenon may be related to the
low level of proliferation of DRH hepatocytes induced by LN
and to hepatocarcinogenesis resistance in DRH rats.
The resistance of DRH hepatocytes to DEN and CCl4
was also linked to the Drh1 locus. Liu et al. [9]r e p o r t e d
that when a 3 -Me-DAB diet was continuously provided,
17.9%, 11.3%, and 5.7% of the total liver tissues were made
up of ﬁbrotic areas in F344, DRH.F344-Drh1, and DRH
rats, respectively, suggesting that the Drh1 locus may also
be related to resistance to chronic hepatic injury induced by
3 -Me-DAB. Hepatic injury of the liver tissue is considered
important for the selective growth of preneoplastic hepato-
cytes during hepatocarcinogenesis [25]. In fact, transplanted
DRH preneoplastic hepatocytes proliferate at high rates in
Donryu livers treated with 2-AAF/PH, while transplanted
Donryu hepatocytes proliferate at low rates in DRH livers
treated with the same regimen [8]. Therefore, the tissue
environment of the DRH liver may be less eﬀective for
the selective growth of preneoplastic hepatocytes during
hepatocarcinogen treatment, which may be one of the
mechanisms of hepatocarcinogenesis resistance in DRH rats.
ThelowlevelofproliferationofDRHhepatocytesinvitro
is not linked to the Drh1 locus. Hepatocyte proliferation
in vitro is associated with complex changes, including the
loss of hepatocyte-speciﬁc gene expression (e.g., albumin
and cytochrome p4502A1), the gain of bile duct epithelium-
speciﬁc gene expression (e.g., cytokeratin 19), and the acti-
vation of speciﬁc transcription factors (e.g., AP1 and NFκB)
[17]. In addition, the signals mediated by the extracellular
matrix inﬂuence proliferation and gene expression in hepa-
tocytes in vitro [17, 26–28]. Although the basis for the low
level of proliferation of DRH hepatocytes in vitro remains
to be investigated, DRH hepatocytes may have inherently
low responsiveness to hepatocyte growth factors. Because
the proliferation of preneoplastic hepatocytes is considered
to be dependent on extracellular signals rather than on
autonomous growth [25], the low level of proliferation
of DRH hepatocytes in vitro may be related to the small8 International Journal of Hepatology
preneoplastic hepatocytic lesions present in DRH livers
during hepatocarcinogenesis.
The small nuclear size of DRH hepatocytes was also not
linked to the Drh1 locus. Although hepatocytes have single-
diploid nuclei during development, double-nuclear diploid
and single- or double-nuclear tetraploid cells constitute the
main populations in the adult liver [29]. Double-nuclear
cells may be generated by a lack of cytokinesis after DNA
synthesis, while tetraploid cells may be generated by a lack
of mitosis after DNA synthesis in diploid cells [29]. On
the other hand, polyploid hepatocytes increase in number
under various pathophysiological conditions, including liver
regeneration after partial hepatectomy [30], exposure to
hepatotoxic chemicals such as retrorsine [31, 32], and
metabolic defects associated with copper or iron deposition
[33, 34]. Moreover, polyploid hepatocytes have been shown
to express senescence phenotypes [35], including increased
expression of p21 and β-galactosidase, which has been
demonstrated in senescent cells [36, 37], low replication
capacity, and high levels of apoptosis [35]. It is possible that
suppressed or delayed tetraploidization in DRH hepatocytes
reﬂects a diminished senescence phenotype, which may be
linked to hepatocarcinogenesis resistance in DRH rats.
In summary, DRH hepatocytes possess unique proper-
ties, some of which are linked to the Drh1 locus. However,
it remains to be investigated whether other properties are
linked to the Drh2 locus. Identiﬁcation of the genes present
in these loci may contribute to the clariﬁcation of the
mechanism(s) and prevention of hepatocarcinogenesis.
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